Department of Nursing and Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan City (701), Taiwan.
J Crit Care. 2010 Jun;25(2):294-9. doi: 10.1016/j.jcrc.2009.12.007. Epub 2010 Mar 1.
Patients with neurologic system problems are among the most common patients readmitted to the intensive care unit (ICU). Readmission predictors for neurologic ICU patients have not been established. Previous research suggests that the Revised Acute Physiology and Chronic Health Evaluation (APACHE II) score is one indication of the critical status of ICU-admitted patients; however, the ability of the discharge APACHE II to predict readmission to the ICU requires further study. The purpose of this study was to investigate the ability of the APACHE II scoring system to predict ICU readmission of neurosurgical and ICU patients.
A retrospective case-controlled comparison study and a review of patient records for all patients admitted to 8 ICUs from January 2003 to June 2005 (N = 753) were conducted. Readmitted neurosurgery ICU patients were matched with 58 randomly selected nonreadmitted patients.
Nine variables were significantly different between the readmission and case-controlled group. The APACHE II discharge score was the only significant predictor and was able to predict 18.6% of neurologic ICU readmissions. The risk of ICU readmission increased when the APACHE II score at the time of discharge exceeded 8.5 points.
The risk of ICU readmission of neurologic ICU patients can be predicted by determining APACHE II score upon ICU discharge.
神经系统疾病患者是最常被重新收入重症监护病房(ICU)的患者之一。尚未确定神经科 ICU 患者的再入院预测因素。先前的研究表明,修订后的急性生理学和慢性健康评估(APACHE II)评分是 ICU 入院患者危急状态的一个指标;然而,出院时的 APACHE II 评分预测 ICU 再入院的能力还需要进一步研究。本研究旨在探讨 APACHE II 评分系统预测神经外科和 ICU 患者 ICU 再入院的能力。
对 2003 年 1 月至 2005 年 6 月期间 8 个 ICU 收治的所有患者(N=753)进行回顾性病例对照比较研究和患者病历回顾。将重新入住神经外科 ICU 的患者与随机选择的 58 名未重新入住的患者进行匹配。
再入院组和病例对照组之间有 9 个变量存在显著差异。APACHE II 出院评分是唯一显著的预测因素,能够预测 18.6%的神经科 ICU 再入院。当出院时的 APACHE II 评分超过 8.5 分时,ICU 再入院的风险增加。
通过确定 ICU 出院时的 APACHE II 评分,可以预测神经科 ICU 患者的 ICU 再入院风险。